Skip to content
Clinical Trials – home
SloveniaBack to Slovenia

Clinical trials in Maribor – page 2

29 clinical trials in Maribor, Slovenia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SloveniaOur site in SloveniaKlinicnaPreskusanja.si(opens in a new tab)
Maribor at a glance
29
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

29 trials in Maribor

Open in trial search
Registered drug
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Dermatitis atopic

Not recruiting
Investigational
Countries:SloveniaSlovenia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.
Registered drug
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Dermatitis atopic

Not recruiting
Registered drug
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

IgA nephropathy

Not recruiting
Investigational
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Iptacopan
  • Sponsor:Novartis Pharma AG
Countries:SloveniaSlovenia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lutikizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Investigational
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Quinidine Sulfate
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Other cities in Slovenia

The busiest research cities in the country

All 17 cities in Slovenia

Clinical research in Maribor

What the registry says about research in the country

01 Neurological Disorders

Research focusing on breakthrough treatments for Multiple Sclerosis and neurodegenerative conditions, including evaluations of novel therapies like remibrutinib and ocrelizumab. Studies are examining treatment effectiveness for patients with various forms of MS.

  • Relapsing Multiple Sclerosis (RMS)
  • Early Alzheimer's Disease
  • Refractory Focal Onset Epilepsy

Innovative trials exploring cognitive improvement and disease progression reduction.

02 Autoimmune Conditions

Comprehensive studies evaluating treatments for Sjögren's Syndrome and other autoimmune disorders, with particular focus on systemic manifestations and long-term safety profiles.

  • IgA Nephropathy
  • Hidradenitis Suppurativa
  • Crohn's Disease

Trials aimed at developing targeted therapies for moderate to severe disease manifestations.

03 Oncology Research

Advanced clinical investigations in Non-Small Cell Lung Cancer and gynecological cancers, evaluating novel combination therapies and maintenance treatments.

  • Advanced Endometrial Cancer
  • Multiple Myeloma
  • PD-L1 High NSCLC

Focus on immunotherapy combinations and targeted treatment approaches.

04 Critical Care Medicine

Studies addressing acute medical conditions including cardiogenic shock and severe respiratory infections, with emphasis on improving patient outcomes.

  • Traumatic Injury
  • Community-Acquired Pneumonia
  • Acute Myocardial Infarction

Research aimed at reducing mortality and improving treatment protocols in critical care settings.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.